Equities research analysts at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a report released on Saturday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Price Performance
AMPE stock opened at $0.00 on Friday. The company has a market capitalization of $3,064.50, a price-to-earnings ratio of 0.00 and a beta of 3.90. Ampio Pharmaceuticals has a one year low of $0.00 and a one year high of $0.45.
Ampio Pharmaceuticals Company Profile
Want More Great Investing Ideas?
Read More
- Five stocks we like better than Ampio Pharmaceuticals
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Google Is Betting Big on Nuclear Reactors—Should You?
- Manufacturing Stocks Investing
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- What Are Dividends? Buy the Best Dividend Stocks
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
